Two studies linked a type of lesions with chronic inflammation, paramagnetic rim lesions, with worse MS disability ...

Columnist Leigh Anne Nelson has gone for the ride as she's been changing neurologists and nurse practitioners. But any change ...

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

A high genetic risk for MS, along with exposure to tobacco or other environmental factors, can affect early brain development ...

Blood storage conditions, age, and other factors can influence the levels of NfL, a nerve damage biomarker used in MS ...

Columnist Desiree Lama has always known she wanted to help people; now she is achieving that goal through MS advocacy.

Vaccination didn't increase the risk of children or adolescents being diagnosed with pediatric MS within five years, a study ...

Tiziana's Phase 2 trial testing foralumab for nonactive secondary progressive multiple sclerosis (SPMS) has added six U.S.

Children with MS from poorer families or other disadvantaged circumstances tend to have more inflammation and brain damage, a ...

Columnist Ben Hofmeister isn't as worried about his children inheriting MS as he is about them seeing the reality of living with the disease.

When faced with the obstacle course that is MS, columnist Ben Hofmeister remembers his strategy while in the Army Special Forces: Don't quit.

Hospitalization for severe COVID-19 more than doubles risk of MS, according to a study involving nearly 10 million people in ...